Symphony Capital Partners Overview

  • Fund Strategy
  • Venture

  • Fund Status
  • Liquidated

  • Size
  • $300M

  • Vintage
  • 2004

Vintage

  • Dry Powder

Symphony Capital Partners General Information

Description

Symphony Capital Partners was a venture capital fund managed by Symphony Capital. The fund was located in New York, New York.

Contact Information

Fund Manager
Fund Manager Website
Fund Category
Venture Capital
Open Date
Fund Family
Symphony Capital Partners
Native Currency
USD
Fund Manager's Location
  • 485 Madison Avenue
  • 7th Floor
  • New York, NY 10022
  • United States
Fund Domiciles
United States: Delaware

Symphony Capital Partners Investments (1)

Symphony Capital Partners has made one investment. Its deal was a PIPE with Exelixis for , made on 02-Nov-2004.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Exelixis 02-Nov-2004 PIPE Drug Discovery Generating Revenue
To view Symphony Capital Partners’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Symphony Capital Partners Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

Symphony Capital Partners Limited Partners (6)

HBM Healthcare Investments is one of Symphony Capital Partners’s 6 limited partners. Its latest Original was on 01-Jan-2005.

Limited Partner Name Type Status Commitment Date Commitment Type
HBM Healthcare Investments Current 01-Jan-2005 Original
Mayo Pension Plan Current 01-Jan-2005 Original
National Railroad Retirement Investment Trust Current 01-Jan-2005 Original
Nature Sacred Former 01-Jan-2005 Original
The William K. Warren Foundation Foundation Current 01-Jan-2005 Original
You’re viewing 5 of 6 limited partners. Get the full list »

Symphony Capital Partners Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

Symphony Capital Partners Returns History

Period Contribution (by all LPs) Dry Powder Distribution (to all LPs) NAV Total Fund Distr+NAV IRR DPI RVPI TVPI Dry Powder %

This information is available in the PitchBook Platform. To explore Symphony Capital Partners‘s full profile, request access.

Request a free trial

Symphony Capital Partners Benchmark (25)

Fund Name Fund Type Vintage IRR Quartile As of Date
Sevin Rosen Fund IX
Sanderling VI 31-Mar-2026
InterWest Partners IX 31-Dec-2024
Kleiner Perkins Caufield & Byers XI 31-Mar-2016
Prism Venture Partners V 30-Sep-2023
Oak Investment Partners XI 30-Jun-2026
Ventures West 9
Symphony Capital Partners 31-Dec-2014
Venrock Associates IV 31-Dec-2018
Frazier Healthcare V 31-Mar-2026
You’re viewing 10 of 25 funds. Get the full list »

Symphony Capital Partners FAQs

  • What is Symphony Capital Partners?

    Symphony Capital Partners was a venture capital fund managed by Symphony Capital.

  • Who manages Symphony Capital Partners?

    Symphony Capital Partners is managed by Symphony Capital.

  • Where is Symphony Capital Partners domiciled?

    Symphony Capital Partners is domiciled in United States: Delaware.

  • What is Symphony Capital Partners's size?

    Symphony Capital Partners has a size of $300M.

  • What type of fund is Symphony Capital Partners?

    The fund type of Symphony Capital Partners is Venture.

  • What is the status of Symphony Capital Partners?

    Symphony Capital Partners is liquidated.

  • What has Symphony Capital Partners invested in?

    Symphony Capital Partners has invested in Exelixis within the Drug Discovery industry.

  • What has Symphony Capital Partners invested in recently?

    Symphony Capital Partners's latest investment was on 02-Nov-2004 in Exelixis, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process